PL331561A1
(en)
|
1996-08-12 |
1999-07-19 |
Yoshitomi Pharmaceutical |
Pharmaceutic composition containing an inhibitor of rho kinase
|
US20080233098A1
(en)
*
|
1997-10-31 |
2008-09-25 |
Mckerracher Lisa |
RHO Family Antagonists and Their Use to Block Inhibition of Neurite Outgrowth
|
EP1074545A4
(de)
*
|
1998-04-23 |
2001-08-22 |
Hiroyoshi Hidaka |
Isochinolinsulfonamid-derivate und sie als aktiven bestandteil enthaltende medikamente
|
ATE307609T1
(de)
*
|
1998-08-17 |
2005-11-15 |
Senju Pharma Co |
Präventiva/mittel zur glaukombehandlung
|
US7169783B2
(en)
*
|
1998-11-02 |
2007-01-30 |
Universite De Montreal |
(+)-Trans-4-(1-aminoethyl)-1-(4-pyridycarbamoyl)-cyclohexane and method for promoting neural growth in the central nervous system and in a patient at a site of neuronal lesion
|
AU3328600A
(en)
*
|
1999-03-25 |
2000-10-16 |
Santen Pharmaceutical Co. Ltd. |
Ocular tension-lowering agents
|
WO2000057913A1
(fr)
*
|
1999-03-25 |
2000-10-05 |
Welfide Corporation |
Prophylaxies/remedes pour la pneumonie interstitielle et la fibrose pulmonaire
|
EP1174150A4
(de)
*
|
1999-04-22 |
2004-06-16 |
Mitsubishi Pharma Corp |
Präventiv-/heilmittel für angiostenose
|
EP1177796B1
(de)
*
|
1999-04-27 |
2011-04-27 |
Mitsubishi Tanabe Pharma Corporation |
Arzneimittel zur präventiven oder therapeutische Behandlung von Lebererkrankungen
|
AU5250400A
(en)
*
|
1999-06-18 |
2001-01-09 |
Mitsubishi Pharma Corporation |
Osteogenesis promoters
|
JP2001081031A
(ja)
*
|
1999-08-30 |
2001-03-27 |
Schering Ag |
溶解性および経口吸収性を改善したベンズアミド誘導体含有製剤
|
AU6865100A
(en)
*
|
1999-09-02 |
2001-04-10 |
Mitsubishi Pharma Corporation |
Osteogenesis promoting agents
|
WO2001022997A1
(fr)
*
|
1999-09-29 |
2001-04-05 |
Mitsubishi Pharma Corporation |
Analgesiques
|
US7217722B2
(en)
|
2000-02-01 |
2007-05-15 |
Kirin Beer Kabushiki Kaisha |
Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
|
KR100818060B1
(ko)
*
|
2000-03-16 |
2008-03-31 |
미쯔비시 웰 파마 가부시키가이샤 |
아미드 화합물 및 그의 용도
|
CA2404594C
(en)
*
|
2000-03-31 |
2010-12-21 |
Mitsubishi Pharma Corporation |
Agent for prophylaxis and treatment of renal disease
|
US6930115B2
(en)
|
2000-06-23 |
2005-08-16 |
Mitsubishi Pharma Corporation |
Antitumor effect potentiators
|
WO2002024667A1
(en)
*
|
2000-09-20 |
2002-03-28 |
Merck Patent Gmbh |
4-amino-quinazolines
|
EP1318985A2
(de)
*
|
2000-09-20 |
2003-06-18 |
MERCK PATENT GmbH |
4-amino chinazolinen
|
JP4582561B2
(ja)
*
|
2000-10-23 |
2010-11-17 |
旭化成ファーマ株式会社 |
移植による血管病変の発生抑制剤
|
JP2002139493A
(ja)
*
|
2000-11-01 |
2002-05-17 |
Sumitomo Pharmaceut Co Ltd |
新規なハイスループット・スクリーニング方法
|
CA2325842C
(en)
|
2000-11-02 |
2007-08-07 |
Lisa Mckerracher |
Methods for making and delivering rho-antagonist tissue adhesive formulations to the injured mammalian central and peripheral nervous systems and uses thereof
|
US20020177207A1
(en)
*
|
2001-03-14 |
2002-11-28 |
Myriad Genetics, Incorporated |
Tsg101-interacting proteins and use thereof
|
WO2002053143A2
(en)
*
|
2001-01-05 |
2002-07-11 |
The Medical College Of Georgia Research Institute, Inc. |
Treatment of erectile dysfunction with rho-kinase inhibitors
|
JP2002226375A
(ja)
*
|
2001-01-31 |
2002-08-14 |
Asahi Kasei Corp |
線維化予防、治療剤
|
WO2002098370A2
(en)
*
|
2001-03-02 |
2002-12-12 |
Medimmune, Inc. |
Methods of administering/dosing cd2 antagonists for the prevention and treatment of autoimmune disorders or inflammatory disorders
|
HN2002000067A
(es)
*
|
2001-03-23 |
2003-10-24 |
Bayer Healthcare Llc |
Inhibidores de la rho - quinasa.
|
WO2002076977A2
(en)
*
|
2001-03-23 |
2002-10-03 |
Bayer Corporation |
Rho-kinase inhibitors
|
JP4204326B2
(ja)
*
|
2001-04-11 |
2009-01-07 |
千寿製薬株式会社 |
視覚機能障害改善剤
|
US7442686B2
(en)
|
2001-04-12 |
2008-10-28 |
Bioaxone Therapeutique Inc. |
Treatment of macular degeneration with ADP-ribosyl transferase fusion protein therapeutic compositions
|
EP1403255A4
(de)
*
|
2001-06-12 |
2005-04-06 |
Sumitomo Pharma |
Rho-kinase-inhibitoren
|
JP5042419B2
(ja)
*
|
2001-08-15 |
2012-10-03 |
旭化成ファーマ株式会社 |
骨形成促進剤および骨形成促進組成物
|
US7829566B2
(en)
*
|
2001-09-17 |
2010-11-09 |
Werner Mederski |
4-amino-quinazolines
|
DE10153605A1
(de)
*
|
2001-11-02 |
2003-05-28 |
Morphochem Ag Komb Chemie |
Verwendung von Inhibitoren der Rho-Kinasen zur Stimulation des Nervenwachstums, zur Inhibition der Narbengewebsbildung und/oder Reduktion eines Sekundärschadens
|
AU2002349411A1
(en)
*
|
2001-11-30 |
2003-06-17 |
Asahi Kasei Pharma Corporation |
Remedies for primary pulmonary hypertension
|
FR2833840B1
(fr)
*
|
2001-12-21 |
2010-06-18 |
Rytek |
Methodes et compositions pour le traitement de pathologies respiratoires
|
JP4505228B2
(ja)
*
|
2002-01-10 |
2010-07-21 |
バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト |
Rho−キナーゼ阻害剤
|
WO2003062225A1
(en)
*
|
2002-01-23 |
2003-07-31 |
Bayer Pharmaceuticals Corporation |
Pyrimidine derivatives as rho-kinase inhibitors
|
ATE381557T1
(de)
*
|
2002-01-23 |
2008-01-15 |
Bayer Pharmaceuticals Corp |
Rho-kinase inhibitoren
|
GB0206860D0
(en)
*
|
2002-03-22 |
2002-05-01 |
Glaxo Group Ltd |
Compounds
|
US7645878B2
(en)
*
|
2002-03-22 |
2010-01-12 |
Bayer Healthcare Llc |
Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof
|
EP1500643A4
(de)
*
|
2002-04-03 |
2007-03-28 |
Dainippon Sumitomo Pharma Co |
Benzamidinderivate
|
US7425618B2
(en)
|
2002-06-14 |
2008-09-16 |
Medimmune, Inc. |
Stabilized anti-respiratory syncytial virus (RSV) antibody formulations
|
US7132100B2
(en)
|
2002-06-14 |
2006-11-07 |
Medimmune, Inc. |
Stabilized liquid anti-RSV antibody formulations
|
US20040028716A1
(en)
*
|
2002-06-14 |
2004-02-12 |
Marks Andrew R. |
Use of Y-27632 as an agent to prevent restenosis after coronary artery angioplasty/stent implantation
|
CN1681525A
(zh)
*
|
2002-07-12 |
2005-10-12 |
曹义海 |
一种抑制血管渗漏和组织水肿的方法
|
CN100354264C
(zh)
*
|
2002-07-22 |
2007-12-12 |
旭化成制药株式会社 |
5-取代异喹啉衍生物及含有它们的药物
|
US7094789B2
(en)
|
2002-07-22 |
2006-08-22 |
Asahi Kasei Pharma Corporation |
5-substituted isoquinoline derivatives
|
DE10233737A1
(de)
*
|
2002-07-24 |
2004-02-05 |
Morphochem Aktiengesellschaft für kombinatorische Chemie |
Verwendung von Modulatoren des Signaltransduktionswegs über die Proteinkinase Fyn zur Behandlung von Tumorerkrankungen
|
US20040105860A1
(en)
*
|
2002-08-01 |
2004-06-03 |
Losordo Douglas W. |
Cell modulation using a cytoskeletal protein
|
CN100425241C
(zh)
|
2002-08-29 |
2008-10-15 |
参天制药株式会社 |
由Rho激酶抑制剂和前列腺素类物质构成的青光眼治疗剂
|
CA2400996A1
(en)
*
|
2002-09-03 |
2004-03-03 |
Lisa Mckerracher |
1,4-substituted cyclohexane derivatives
|
WO2004024717A1
(ja)
*
|
2002-09-12 |
2004-03-25 |
Kirin Beer Kabushiki Kaisha |
キナーゼ阻害活性を有するイソキノリン誘導体およびそれを含む医薬
|
US20050215601A1
(en)
*
|
2002-09-25 |
2005-09-29 |
Santen Pharmaceutical Co., Ltd. |
Therapeutic agent for rheumatic disease comprising benzamide derivative as active ingredient
|
US8034831B2
(en)
*
|
2002-11-06 |
2011-10-11 |
Celgene Corporation |
Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies
|
US7563810B2
(en)
*
|
2002-11-06 |
2009-07-21 |
Celgene Corporation |
Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
|
JP4314433B2
(ja)
*
|
2002-11-18 |
2009-08-19 |
参天製薬株式会社 |
Rhoキナーゼ阻害剤とβ遮断薬からなる緑内障治療剤
|
AU2003901270A0
(en)
*
|
2003-03-18 |
2003-04-03 |
Medvet Science Pty. Ltd. |
A method of modulating muscle cell functioning
|
AU2004221792C1
(en)
*
|
2003-03-18 |
2009-09-24 |
Medvet Science Pty. Ltd. |
A method of modulating smooth muscle cell functioning by modulating sphingosine kinase mediated signalling
|
GB2400316A
(en)
*
|
2003-04-10 |
2004-10-13 |
Richard Markoll |
Electromagnetic stimulation in patients with osteoporosis
|
KR20110094361A
(ko)
|
2003-04-11 |
2011-08-23 |
메디뮨 엘엘씨 |
재조합 il9 항체 및 그의 용도
|
US20070093513A1
(en)
*
|
2003-04-18 |
2007-04-26 |
Senju Pharmaceutical Co., Ltd. |
Agent for repairing corneal perception
|
US20050014783A1
(en)
*
|
2003-05-29 |
2005-01-20 |
Schering Aktiengesellschaft |
Use of Rho-kinase inhibitors in the treatment of aneurysm and cardiac hypertrophy
|
US20110098232A1
(en)
*
|
2003-05-30 |
2011-04-28 |
Zeilig Charles E |
Methods For The Selective Treatment Of Tumors By Calcium-Mediated Induction Of Apoptosis
|
WO2004108142A2
(en)
*
|
2003-06-06 |
2004-12-16 |
The University Of Manchester |
Inhibitors of tip-1 for treatment tissue damage
|
US7160894B2
(en)
|
2003-06-06 |
2007-01-09 |
Asahi Kasei Pharma Corporation |
Tricyclic compound
|
US20050069553A1
(en)
*
|
2003-08-13 |
2005-03-31 |
Yi Zheng |
Chimeric peptides for the regulation of GTPases
|
WO2005017160A2
(en)
*
|
2003-08-13 |
2005-02-24 |
Children's Hospital Medical Center |
Mobilization of hematopoietic cells
|
ES2458636T3
(es)
|
2003-08-18 |
2014-05-06 |
Medimmune, Llc |
Humanización de anticuerpos
|
US20060228350A1
(en)
*
|
2003-08-18 |
2006-10-12 |
Medimmune, Inc. |
Framework-shuffling of antibodies
|
US7371850B1
(en)
*
|
2003-08-20 |
2008-05-13 |
Myriad Genetics, Inc. |
Method and composition for reducing expression of ROCK-II
|
EP1679308B1
(de)
|
2003-10-15 |
2013-07-24 |
Ube Industries, Ltd. |
Neues indazolderivat
|
US20050238666A1
(en)
*
|
2003-12-05 |
2005-10-27 |
Williams David A |
Methods of enhancing stem cell engraftment
|
PL1696920T3
(pl)
|
2003-12-19 |
2015-03-31 |
Plexxikon Inc |
Związki i sposoby opracowywania modulatorów Ret
|
TW200526224A
(en)
*
|
2003-12-22 |
2005-08-16 |
Alcon Inc |
Short form c-Maf transcription factor antagonists for treatment of glaucoma
|
KR20060127043A
(ko)
*
|
2003-12-22 |
2006-12-11 |
알콘, 인코퍼레이티드 |
녹내장성 망막병증 및 시각신경병증의 치료용 약제
|
MXPA06006862A
(es)
*
|
2003-12-22 |
2007-01-26 |
Alcon Inc |
Agentes para el tratamiento de la retinopatia diabetica y formacion de drusen en degeneracion macular.
|
CN1980929A
(zh)
*
|
2004-02-24 |
2007-06-13 |
比奥阿克松医疗技术股份有限公司 |
4-取代哌啶衍生物
|
WO2005094824A1
(en)
*
|
2004-03-25 |
2005-10-13 |
East Carolina University |
Methods of enhancing cancer therapy by protecting nerve cells
|
US20080096238A1
(en)
*
|
2004-03-30 |
2008-04-24 |
Alcon, Inc. |
High throughput assay for human rho kinase activity with enhanced signal-to-noise ratio
|
US20060115870A1
(en)
*
|
2004-03-30 |
2006-06-01 |
Alcon, Inc. |
High throughput assay for human Rho kinase activity
|
WO2005102345A1
(en)
*
|
2004-03-30 |
2005-11-03 |
Alcon, Inc. |
Use of rho kinase inhibitors in the treatment of hearing loss, tinnitus and improving body balance
|
JP5223072B2
(ja)
|
2004-04-02 |
2013-06-26 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
avβ5インテグリンに関連のある疾患を治療および予防するための方法および組成物
|
ES2553953T3
(es)
*
|
2004-06-03 |
2015-12-15 |
Senju Pharmaceutical Co., Ltd. |
Fármaco para la recuperación de la percepción corneal que contiene un compuesto amida
|
AU2005299355A1
(en)
|
2004-10-27 |
2006-05-04 |
Medimmune, Llc |
Modulation of antibody specificity by tailoring the affinity to cognate antigens
|
FR2879100B1
(fr)
|
2004-12-09 |
2007-07-06 |
Lionel Bueno |
Compositions pour le traitement des pathologies oculaires de surface et de la retine
|
AR054416A1
(es)
*
|
2004-12-22 |
2007-06-27 |
Incyte Corp |
Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas.
|
AU2005322338B2
(en)
*
|
2004-12-27 |
2011-06-09 |
Alcon, Inc. |
Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases
|
WO2006088088A1
(ja)
*
|
2005-02-16 |
2006-08-24 |
Astellas Pharma Inc. |
Rock阻害剤を含有する疼痛治療剤
|
JP5153613B2
(ja)
|
2005-03-18 |
2013-02-27 |
メディミューン,エルエルシー |
抗体のフレームワーク・シャッフル
|
CR9465A
(es)
|
2005-03-25 |
2008-06-19 |
Surface Logix Inc |
Compuestos mejorados farmacocineticamente
|
KR20080025174A
(ko)
|
2005-06-23 |
2008-03-19 |
메디뮨 인코포레이티드 |
응집 및 단편화 프로파일이 최적화된 항체 제제
|
PL1899322T3
(pl)
*
|
2005-06-28 |
2010-02-26 |
Sanofi Aventis |
Pochodne izochinoliny jako inhibitory kinazy Rho
|
BRPI0614063A2
(pt)
|
2005-07-26 |
2011-03-09 |
Sanofi Aventis |
derivados de cicloexilamina isoquinolona
|
EP2385047B1
(de)
|
2005-07-26 |
2013-05-29 |
Sanofi |
Piperidinylsubstituierte Isochinolonderivate
|
EP2258359A3
(de)
|
2005-08-26 |
2011-04-06 |
Braincells, Inc. |
Neurogenese durch Modulation des Muscarinrezeptors mit Sabcomelin
|
CA2620333A1
(en)
|
2005-08-26 |
2007-03-01 |
Braincells, Inc. |
Neurogenesis by muscarinic receptor modulation
|
US7618984B2
(en)
|
2005-08-30 |
2009-11-17 |
Asahi Kasei Pharma Corporation |
Sulfonamide compound
|
US8211919B2
(en)
|
2005-09-02 |
2012-07-03 |
Astellas Pharma Inc. |
Amide derivatives as rock inhibitors
|
JP4832051B2
(ja)
*
|
2005-10-21 |
2011-12-07 |
学校法人順天堂 |
半月体形成性腎病変治療剤
|
CA2625153A1
(en)
|
2005-10-21 |
2007-04-26 |
Braincells, Inc. |
Modulation of neurogenesis by pde inhibition
|
US7893050B2
(en)
|
2005-10-26 |
2011-02-22 |
Asahi Kasei Pharma Corporation |
Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
|
EP1942879A1
(de)
|
2005-10-31 |
2008-07-16 |
Braincells, Inc. |
Gaba-rezeptor-vermittelte modulation von neurogenese
|
CA2629342A1
(en)
*
|
2005-12-22 |
2007-07-05 |
Alcon Research, Ltd. |
(indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)- pyrazines for treating rho kinase-mediated diseases and conditions
|
US7867999B1
(en)
|
2005-12-22 |
2011-01-11 |
Alcon Research, Ltd. |
Hydroxyamino- and amino-substituted pyridine analogs for treating rho kinase-mediated diseases and conditions
|
US20100216734A1
(en)
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
JP2009536667A
(ja)
|
2006-05-09 |
2009-10-15 |
ブレインセルス,インコーポレイティド |
5ht受容体介在性の神経新生
|
JP2009536669A
(ja)
|
2006-05-09 |
2009-10-15 |
ブレインセルス,インコーポレイティド |
アンジオテンシン調節による神経新生
|
TW200815398A
(en)
|
2006-06-08 |
2008-04-01 |
Ube Industries |
A novel indazole derivative having spirocyclic structure in the side chain
|
AU2007279766A1
(en)
|
2006-07-31 |
2008-02-07 |
Senju Pharmaceutical Co., Ltd. |
Aqueous liquid preparation containing amide compound
|
WO2008022182A1
(en)
*
|
2006-08-16 |
2008-02-21 |
The Uab Research Foundation |
Methods for promoting coupling between bone formation and resorption
|
KR101314362B1
(ko)
|
2006-08-28 |
2013-10-10 |
라 졸라 인스티튜트 포 앨러지 앤드 이뮤놀로지 |
길항성 인간 light-특이적 인간 모노클로날 항체
|
GB0617222D0
(en)
*
|
2006-08-31 |
2006-10-11 |
Vereniging Het Nl Kanker I |
Antibiotics
|
AU2007292848A1
(en)
|
2006-09-08 |
2008-03-13 |
Braincells, Inc. |
Combinations containing a 4-acylaminopyridine derivative
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
WO2008049000A2
(en)
*
|
2006-10-18 |
2008-04-24 |
United Therapeutics Corporation |
Combination therapy for pulmonary arterial hypertension
|
WO2008063888A2
(en)
|
2006-11-22 |
2008-05-29 |
Plexxikon, Inc. |
Compounds modulating c-fms and/or c-kit activity and uses therefor
|
WO2008079945A2
(en)
*
|
2006-12-20 |
2008-07-03 |
University Of South Florida |
Rock inhibitors and uses thereof
|
AR064420A1
(es)
*
|
2006-12-21 |
2009-04-01 |
Alcon Mfg Ltd |
Composiciones farmaceuticas oftalmicas que comprenden una cantidad efectiva de analogos de 6-aminoimidazo[1,2b]piridazinas, utiles para el tratamiento del glaucoma y/o controlar la presion intraocular normal o elevada(iop).
|
JP5313919B2
(ja)
|
2006-12-27 |
2013-10-09 |
サノフイ |
新規な置換イソキノリン及びイソキノリノン誘導体
|
BRPI0720986A2
(pt)
|
2006-12-27 |
2014-03-11 |
Sanofi Aventis |
Derivados de isoquinolina e isoquinolinona substituídos
|
KR101517154B1
(ko)
|
2006-12-27 |
2015-04-30 |
사노피 |
Rho-키나제의 억제제로서의 치환된 이소퀴놀린 및 이소퀴놀리논 유도체
|
ATE490243T1
(de)
|
2006-12-27 |
2010-12-15 |
Sanofi Aventis |
Cycloalkylaminsubstituierte isochinolin- und isochinolinonderivate
|
BRPI0722064A2
(pt)
|
2006-12-27 |
2014-04-01 |
Sanofi Aventis |
Derivados de isoquinolona substituídos por cicloalquilamina
|
MY151953A
(en)
|
2006-12-27 |
2014-07-31 |
Sanofi Aventis |
Cycloalkylamine substituted isoquinoline derivatives
|
GB2458863B
(en)
*
|
2007-01-17 |
2011-10-12 |
Wisconsin Alumni Res Found |
Improved culture of stem cells
|
US8415372B2
(en)
|
2007-02-27 |
2013-04-09 |
Asahi Kasei Pharma Corporation |
Sulfonamide compound
|
US7964613B2
(en)
|
2007-02-28 |
2011-06-21 |
Asahi Kasei Pharma Corporation |
Sulfonamide compound
|
KR101566171B1
(ko)
|
2007-03-09 |
2015-11-06 |
삼성전자 주식회사 |
디지털 저작권 관리 방법 및 장치
|
KR101540823B1
(ko)
|
2007-03-30 |
2015-07-30 |
메디뮨 엘엘씨 |
항체 제제
|
WO2008134828A2
(en)
|
2007-05-04 |
2008-11-13 |
Katholieke Universiteit Leuven |
Tissue degeneration protection
|
KR101246392B1
(ko)
|
2007-07-02 |
2013-03-21 |
아사히 가세이 파마 가부시키가이샤 |
술폰아미드 화합물 및 그 결정
|
MX2010000617A
(es)
|
2007-07-17 |
2010-05-17 |
Plexxikon Inc |
Compuestos y metodos para modulacion de cinasa, e indicaciones de estos.
|
US9248125B2
(en)
*
|
2007-08-29 |
2016-02-02 |
Senju Pharmaceutical Co., Ltd. |
Agent for promoting corneal endothelial cell adhesion
|
BRPI0912337A2
(pt)
*
|
2008-05-12 |
2019-09-24 |
Amnestix Inc |
composto método para melhorar memória em paciente, e, método para tratar condições
|
US8524737B2
(en)
|
2008-06-24 |
2013-09-03 |
Sanofi |
Bi- and polycyclic substituted isoquinoline and isoquinolinone derivatives
|
MY153615A
(en)
|
2008-06-24 |
2015-02-27 |
Sanofi Aventis |
6-substituted isoquinolines and isoquinolinones
|
ES2541827T3
(es)
|
2008-06-24 |
2015-07-27 |
Sanofi |
Isoquinolinas e isoquinolinonas sustituidas como inhibidores de Rho-cinasa
|
CN102105167A
(zh)
|
2008-07-24 |
2011-06-22 |
国立大学法人大阪大学 |
轴性近视的预防或治疗剂
|
WO2010032875A2
(en)
*
|
2008-09-18 |
2010-03-25 |
Astellas Pharma Inc. |
Heterocyclic carboxamide compounds
|
EP2177218A1
(de)
|
2008-10-15 |
2010-04-21 |
Medizinische Universität Wien |
Regenerative Therapie
|
EP2177510A1
(de)
|
2008-10-17 |
2010-04-21 |
Universität des Saarlandes |
Allosterische Proteinkinasemodulatoren
|
WO2010099217A1
(en)
|
2009-02-25 |
2010-09-02 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
WO2010114928A2
(en)
|
2009-04-03 |
2010-10-07 |
F.Hoffmann-La Roche Ag |
Compositions and uses thereof
|
US8329724B2
(en)
|
2009-08-03 |
2012-12-11 |
Hoffmann-La Roche Inc. |
Process for the manufacture of pharmaceutically active compounds
|
WO2011021221A2
(en)
|
2009-08-17 |
2011-02-24 |
Reliance Life Sciences Pvt. Ltd. |
Compositions for spinal cord injury
|
MX337982B
(es)
|
2009-10-16 |
2016-03-30 |
Scripps Research Inst |
Induccion de celulas pluripotentes.
|
NZ629615A
(en)
|
2009-11-06 |
2016-01-29 |
Plexxikon Inc |
Compounds and methods for kinase modulation, and indications therefor
|
CN102188697B
(zh)
*
|
2010-03-03 |
2014-11-05 |
中国医学科学院药物研究所 |
重组人Rho激酶在制备药物中的应用
|
WO2011133948A2
(en)
|
2010-04-22 |
2011-10-27 |
Longevity Biotech, Inc. |
Highly active polypeptides and methods of making and using the same
|
EP2655601A4
(de)
|
2010-12-22 |
2014-09-10 |
Fate Therapeutics Inc |
Zellkulturplattform für einzelzellsortierung und verbesserte neuprogrammierung von ipscs
|
US20120189633A1
(en)
|
2011-01-26 |
2012-07-26 |
Kolltan Pharmaceuticals, Inc. |
Anti-kit antibodies and uses thereof
|
JP5941069B2
(ja)
|
2011-02-07 |
2016-06-29 |
プレキシコン インコーポレーテッドPlexxikon Inc. |
キナーゼ調節のための化合物および方法、ならびにそれに対する適応症
|
AR085279A1
(es)
|
2011-02-21 |
2013-09-18 |
Plexxikon Inc |
Formas solidas de {3-[5-(4-cloro-fenil)-1h-pirrolo[2,3-b]piridina-3-carbonil]-2,4-difluor-fenil}-amida del acido propano-1-sulfonico
|
EP2628482A1
(de)
|
2012-02-17 |
2013-08-21 |
Academisch Medisch Centrum |
Rho Kinase Inhibitoren in der Verwendung zur Behandlung von Neuroblastoma
|
EP2846834A1
(de)
*
|
2012-05-08 |
2015-03-18 |
Syddansk Universitet |
Anabolische verbindungen zur behandlung und prävention von knochenverlustserkrankungen
|
US9150570B2
(en)
|
2012-05-31 |
2015-10-06 |
Plexxikon Inc. |
Synthesis of heterocyclic compounds
|
NZ630363A
(en)
|
2012-07-25 |
2018-09-28 |
Celldex Therapeutics Inc |
Anti-kit antibodies and uses thereof
|
JP2015533832A
(ja)
|
2012-10-09 |
2015-11-26 |
アイジェニカ バイオセラピューティクス インコーポレイテッド |
抗C16orf54抗体およびその使用方法
|
US9789164B2
(en)
|
2013-03-15 |
2017-10-17 |
Longevity Biotech, Inc. |
Peptides comprising non-natural amino acids and methods of making and using the same
|
CN105050600B
(zh)
|
2013-04-24 |
2018-09-28 |
国立大学法人九州大学 |
眼底疾病治疗剂
|
WO2014177699A1
(en)
*
|
2013-05-03 |
2014-11-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Rhoa (rock) inhibitors for the treatment of enflammatory bowel disease
|
SG11201509982UA
(de)
|
2013-06-06 |
2016-04-28 |
Igenica Biotherapeutics Inc |
|
KR20160054501A
(ko)
|
2013-08-26 |
2016-05-16 |
맵백스 테라퓨틱스, 인코포레이티드 |
시알릴-루이스 a에 대한 사람 항체 코드화 핵산
|
KR102340553B1
(ko)
|
2014-03-04 |
2021-12-21 |
페이트 세러퓨틱스, 인코포레이티드 |
개선된 재프로그래밍 방법 및 세포 배양 플랫폼
|
GB201403775D0
(en)
|
2014-03-04 |
2014-04-16 |
Kymab Ltd |
Antibodies, uses & methods
|
NZ764877A
(en)
|
2014-06-04 |
2023-12-22 |
Biontech Res And Development Inc |
Human monoclonal antibodies to ganglioside gd2
|
SG10201806498RA
(en)
|
2014-06-27 |
2018-08-30 |
Univ California |
Cultured mammalian limbal stem cells, methods for generating the same, and uses thereof
|
PT3333191T
(pt)
|
2014-12-11 |
2020-12-15 |
Pf Medicament |
Anticorpos anti-c10orf54 e suas utilizações
|
US10106525B2
(en)
|
2015-01-26 |
2018-10-23 |
BioAxone BioSciences, Inc. |
Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
|
US10857157B2
(en)
|
2015-01-26 |
2020-12-08 |
BioAxone BioSciences, Inc. |
Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors
|
US10149856B2
(en)
|
2015-01-26 |
2018-12-11 |
BioAxone BioSciences, Inc. |
Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors
|
WO2016130539A2
(en)
|
2015-02-09 |
2016-08-18 |
Memorial Sloan Kettering Cancer Center |
Multi-specific antibodies with affinity for human a33 antigen and dota metal complex and uses thereof
|
PL3265123T3
(pl)
|
2015-03-03 |
2023-03-13 |
Kymab Limited |
Przeciwciała, zastosowania i sposoby
|
JP6480025B2
(ja)
|
2015-06-24 |
2019-03-06 |
日東電工株式会社 |
イオン性化合物及び組成物並びにその使用
|
WO2017064119A1
(en)
|
2015-10-13 |
2017-04-20 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for the treatment of retinal capillary non-perfusion
|
EP4088719A1
(de)
|
2015-10-13 |
2022-11-16 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Verfahren und pharmazeutische zusammensetzungen zur behandlung von kapillarer nichtperfusion der netzhaut
|
EP3362570A4
(de)
|
2015-10-16 |
2019-03-20 |
Fate Therapeutics, Inc. |
Plattform zur induktion und wartung von grundzustandspluripotenz
|
CN108925136B
(zh)
|
2015-12-02 |
2022-02-01 |
斯特赛恩斯公司 |
特异于糖基化的btla(b和t淋巴细胞衰减因子)的抗体
|
CN109415437B
(zh)
|
2015-12-02 |
2022-02-01 |
斯特库伯株式会社 |
与btn1a1免疫特异性结合的抗体和分子及其治疗用途
|
US11779604B2
(en)
|
2016-11-03 |
2023-10-10 |
Kymab Limited |
Antibodies, combinations comprising antibodies, biomarkers, uses and methods
|
US11198680B2
(en)
|
2016-12-21 |
2021-12-14 |
BioAxone BioSciences, Inc. |
Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
|
CA3065301A1
(en)
|
2017-05-31 |
2018-12-06 |
Stcube & Co., Inc. |
Antibodies and molecules that immunospecifically bind to btn1a1 and the therapeutic uses thereof
|
CN111051346A
(zh)
|
2017-05-31 |
2020-04-21 |
斯特库伯株式会社 |
使用免疫特异性结合btn1a1的抗体和分子治疗癌症的方法
|
US11542331B2
(en)
|
2017-06-06 |
2023-01-03 |
Stcube & Co., Inc. |
Methods of treating cancer using antibodies and molecules that bind to BTN1A1 or BTN1A1-ligands
|
US10537567B2
(en)
|
2017-07-11 |
2020-01-21 |
BioAxone BioSciences, Inc. |
Kinase inhibitors for treatment of disease
|
CN111630069A
(zh)
|
2017-10-13 |
2020-09-04 |
勃林格殷格翰国际有限公司 |
针对Thomsen-nouvelle(Tn)抗原的人抗体
|
US11446273B2
(en)
|
2017-12-21 |
2022-09-20 |
Santen Pharmaceutical Co., Ltd. |
Medicament comprising combination of sepetaprost and Rho-associated coiled-coil containing protein kinase inhibitor
|
WO2020016459A1
(en)
|
2018-07-20 |
2020-01-23 |
Pierre Fabre Medicament |
Receptor for vista
|
US20210292766A1
(en)
|
2018-08-29 |
2021-09-23 |
University Of Massachusetts |
Inhibition of Protein Kinases to Treat Friedreich Ataxia
|
UY38427A
(es)
|
2018-10-26 |
2020-05-29 |
Novartis Ag |
Métodos y composiciones para terapia con células oculares
|
CN111116555B
(zh)
*
|
2018-10-30 |
2023-06-02 |
北京盈科瑞创新药物研究有限公司 |
一种Rho激酶抑制剂及其制备方法和应用
|
WO2020193802A1
(en)
|
2019-03-28 |
2020-10-01 |
Fundación De La Comunidad Valenciana Centro De Investigación Príncipe Felipe |
Polymeric conjugates and uses thereof
|
JP2023522784A
(ja)
|
2020-04-27 |
2023-05-31 |
ノバルティス アーゲー |
眼細胞療法のための方法及び組成物
|
CN111707831A
(zh)
*
|
2020-07-16 |
2020-09-25 |
首都医科大学附属北京朝阳医院 |
Rock激酶活性在辅助诊断sle以及评价sle病情中的应用
|
JP2024503021A
(ja)
|
2021-01-11 |
2024-01-24 |
インサイト・コーポレイション |
Jak経路阻害剤及びrock阻害剤を含む併用療法
|
CN113262226B
(zh)
*
|
2021-04-19 |
2023-05-16 |
杭州市第一人民医院 |
利舒地尔在制备细菌感染治疗药物中的应用
|
WO2023069949A1
(en)
|
2021-10-18 |
2023-04-27 |
Evia Life Sciences Inc. |
Compositions and methods of use thereof for treating liver fibrosis
|
WO2023067394A2
(en)
|
2021-10-22 |
2023-04-27 |
Evia Life Sciences Inc. |
Methods for making extracellular vesicles, and compositions and methods of use thereof
|
WO2023122213A1
(en)
|
2021-12-22 |
2023-06-29 |
Byomass Inc. |
Targeting gdf15-gfral pathway cross-reference to related applications
|
WO2023147107A1
(en)
|
2022-01-31 |
2023-08-03 |
Byomass Inc. |
Myeloproliferative conditions
|